Ozempic maker struggles as it loses ground to rivals in weight-loss market
Novo Nordisk cuts sales and profit forecasts as it continues to lose ground to Mounjaro firm Eli Lilly The maker of Ozempic and Wegovy has cut its sales and profit forecasts as it continues to fall behind in the competitive market for obesity and diabetes treatments. Novo Nordisk’s chief (…)
Site référencé:
The Guardian (South&CentralAsia)
2847.jpg?width=140&quality=85&auto=format&fit=max&s=6294b6e1775d2a17950bf012b978e85a, 2847.jpg?width=460&quality=85&auto=format&fit=max&s=8d07e42f8ba690d3879851340f11f6eb, 2847.jpg?width=700&quality=85&auto=format&fit=max&s=0e2d0a82e6ad2e53e2b962b0aa290d0a
The Guardian (South&CentralAsia)
US supreme court’s liberal justices express skepticism over Trump’s justification of tariffs – live updates
5/11/2025
High-speed rail network possible by 2040, says European Commission
5/11/2025
The Makropulos Case review : Ausrine Stundyte is magnetic in exhilarating – and funny – Janáček staging
5/11/2025
After stifling Mbappé and Vinícius, revived Liverpool hone in on Haaland
5/11/2025
Rob Jetten scored a victory over populism in the Netherlands – but it’s a fragile win
5/11/2025
Harry Potter and the Philosopher’s Stone by JK Rowling audiobook review – an all-star outing
5/11/2025